NCT00437086 2014-10-17Bortezomib in Treating Patients With Advanced Myeloproliferative DisordersMayo ClinicPhase EARLY_PHASE1 Completed30 enrolled
NCT00237627 2012-05-18Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Completed107 enrolled